Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol with Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
Launched by ART FERTILITY CLINICS LLC · Mar 11, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 38 years old.
- • Normal Menstrual cycle of 25-35 days.
- • Body Weight 60to90 kg
- • AMH\>1.3 - \<3 ng/m (Ferraretti and Gianaroli, 2014; Calzada et al., 2019) an antral follicle count (AFC) of \>5 on menstrual cycle days 2-3,
- Exclusion Criteria:
- • History of premature ovulation
- • Azoospermia
- • PCOS
- • Endometriosis AFS ¾
- • Endometrioma
- • Known chromosomal abnormalities
Trial Officials
Barbara Lawrenz, PhD
Study Director
ART Fertility Clinics LLC
About Art Fertility Clinics Llc
Art Fertility Clinics LLC is a leading provider of advanced reproductive healthcare services, specializing in assisted reproductive technologies to support individuals and couples facing fertility challenges. With a commitment to personalized care, state-of-the-art facilities, and a team of experienced specialists, the clinic offers a comprehensive range of services, including in vitro fertilization (IVF), egg freezing, and genetic testing. Art Fertility Clinics LLC is dedicated to advancing reproductive science through innovative clinical trials and research initiatives, ensuring patients receive the most effective and up-to-date treatment options available.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abu Dhabi, , United Arab Emirates
Dubai, , United Arab Emirates
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
